NCT06521567 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06521567
Title	A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	GlaxoSmithKline
Indications	osteosarcoma high grade glioma hepatoblastoma rhabdomyosarcoma hepatocellular carcinoma glioblastoma low grade glioma diffuse midline glioma, H3 K27M-mutant fibrolamellar carcinoma Hodgkin's lymphoma melanoma
Therapies	Cobolimab + Dostarlimab-gxly
Age Groups:	adult \| child
Covered Countries	USA \| ITA \| ESP \| DNK \| CZE

Filter rows:

Showing 1 to 13 of 13 entries

Facility	Status	City	State	Zip	Country	Details
GSK Investigational Site	RECRUITING	Los Angeles	California	90048	United States	Details
GSK Investigational Site	RECRUITING	Iowa City	Iowa	52242-1009	United States	Details
GSK Investigational Site	RECRUITING	Hackensack	New Jersey	07601	United States	Details
GSK Investigational Site	RECRUITING	Cincinnati	Ohio	45229	United States	Details
GSK Investigational Site	RECRUITING	Providence	Rhode Island	02903	United States	Details
GSK Investigational Site	RECRUITING	Phaha 5		15006	Czechia	Details
GSK Investigational Site	RECRUITING	Copenhagen		2100	Denmark	Details
GSK Investigational Site	RECRUITING	Bologna		40138	Italy	Details
GSK Investigational Site	RECRUITING	Napoli		80123	Italy	Details
GSK Investigational Site	RECRUITING	Barcelona		08035	Spain	Details
GSK Investigational Site	RECRUITING	Madrid		28009	Spain	Details
GSK Investigational Site	RECRUITING	Madrid		28046	Spain	Details
GSK Investigational Site	RECRUITING	Valencia		46026	Spain	Details

Showing 1 to 13 of 13 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT06521567Clinical Trial Detail